Skip to main content

Table 1 Phase II and Phase III randomized trials of bolus versus infusion thrombolytic therapy for acute myocardial infarction

From: Meta-analysis of randomized phase II trials to inform subsequent phase III decisions

Trial name, year published

Length of follow-up

Outcome

Sample size, N

Number of events (%)

Bolus

Infusion

Bolus

Infusion

Phase II trials

      

RAPID [11] 1995

30 days

ICH

452

154

1 (0.2)

4 (2.6)

Reinfarction

20 (4.4)

7 (4.5)

RAPID-II [12] 1996

35 days

ICH

169

155

2 (1.2)

3 (1.9)

Reinfarction

8 (4.7)

7 (4.5)

Kawai et al. [13] 1997

7 days

ICH

97

102

0 (0)

1 (1.0)

Reinfarction

4 (4.1)

7 (6.9)

Vanderschueren et al. [14] 1997

Hospital stay

ICH

50

52

0 (0)

0 (0)

Reinfarction

5 (10.0)

7 (13.4)

BASE [15] 1998

Hospital stay

ICH

139

53

2 (1.4)

0 (0)

Reinfarction

9 (6.5)

1 (1.9)

DOUBLE [16] 1998

30 days

ICH

224

237

2 (0.9)

1 (0.4)

Reinfarction

5 (2.2)

12 (5.1)

lnTIME [17] 1998

30 days

ICH

478

124

0 (0)

1 (0.8)

Reinfarction

9 (1.9)

8 (6.5)

TIMI 10B [18] 1998

30 days

ICH

540

316

9 (1.7)

6 (1.9)

Reinfarction

28 (5.2)

18 (5.7)

TIMIKO [19] 1998

30 days

ICH

350

268

1 (0.3)

3 (1.1)

Reinfarction

11 (3.1)

9 (3.4)

Phase III trials

      

INJECT [22] 1995

35 days

ICH

2992

2994

23 (0.8)

11 (0.4)

Reinfarction

150 (5.0)

162 (5.4)

COBALT [23] 1997

30 days

ICH

3585

3584

40 (1.1)

29 (0.8)

Reinfarction

140 (3.9)

147 (4.1)

GUSTO III [24] 1997

30 days

ICH

10138

4921

92 (0.9)

43 (0.9)

Reinfarction

426 (8.7)

207 (2.0)

BIRD [26] 1998

30 days

ICH

1196

1212

9 (0.8)

9 (0.7)

Reinfarction

-

-

ASSENT-2 [25] 1999

30 days

ICH

8461

8488

79 (0.9)

80 (0.9)

Reinfarction

347 (4.1)

325 (3.8)

lnTIME-II [27] 1999

30 days

ICH

10051

5027

114 (1.1)

31 (0.6)

Reinfarction

-

-

  1. ICH, intracranial hemorrhage.